Recent news highlights strong revenue growth and operational updates for American Shared Hospital Services, including a 17% year-over-year revenue increase for Q1 2025 and ongoing expansion plans.

• American Shared Hospital Services reported strong revenue growth, highlighting operational momentum [N1].
• The company announced a 17% year-over-year revenue growth for Q1 2025 and outlined expansion plans [N3].
• An earnings conference call for Q1 2025 was held on May 15, 2025 [N2].
• Quarterly earnings results were reported in early April 2025 [N4].
• Recent insider trading and hedge fund activity were discussed in a March 2025 earnings preview [N5].

The company’s recent revenue growth, including a 17% year-over-year increase reported for Q1 2025, and expansion plans indicate operational momentum. The diversification of product offerings beyond Gamma Knife to include LINAC and PBRT systems may broaden market opportunities. The company’s ownership and operation of direct patient service facilities in multiple countries provide additional revenue streams. Improvements in operational efficiency and resolution of equipment downtime could enhance profitability.

The company reported a net loss in 2025, with operational challenges such as physician turnover and equipment downtime impacting the direct patient segment. Liquidity ratios indicate current liabilities exceed current assets, raising concerns about short-term financial flexibility. The credit agreement matures in April 2026, and failure to extend or refinance could exacerbate liquidity constraints. Customer concentration risk is significant, with a few customers accounting for a large portion of revenue and receivables. Dependence on a single equipment manufacturer may limit flexibility and increase risk.

American Shared Hospital Services operates in a niche market providing specialized radiosurgery and radiation therapy equipment and services, including Gamma Knife and PBRT systems. The high capital cost and specialized nature of the equipment, along with established contracts with hospitals and ownership of treatment facilities, create barriers to entry. The company’s long-term contracts and relationships with a limited number of customers contribute to its competitive position. However, customer concentration and reliance on a single equipment manufacturer (Elekta) present vulnerabilities.

• Liquidity Risk: Current liabilities exceed current assets as of December 31, 2025, with a current ratio of 0.76 and cash ratio of 0.15, indicating potential liquidity constraints. The company’s credit facilities mature in April 2026, and inability to extend or refinance could impact operations and going concern status [S1].
• Customer Concentration: Two customers accounted for approximately 26% and 31% of revenue in 2025, and four locations accounted for 81% of accounts receivable, exposing the company to significant revenue and credit risk if any major customer relationship deteriorates [S1].
• Operational Challenges: The direct patient services segment experienced net losses due to physician turnover and equipment downtime, which affected procedure volumes and revenue [S1].
• Dependence on Single Equipment Manufacturer: All radiosurgery devices have been purchased through Elekta, which may limit negotiating power and expose the company to supply chain or technological risks [S1].

• American Shared Hospital Services (ASHS) provides turn-key technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, primarily through medical equipment leasing and direct patient services segments [S1].
• The leasing segment operates via fee-per-use or revenue sharing contracts, sharing revenue and operating costs with hospitals. As of December 31, 2025, the company leased seven Gamma Knife systems and one Proton Beam Radiation Therapy (PBRT) system [S1].
• The direct patient services segment includes ownership and operation of two single-unit Gamma Knife facilities in Lima, Peru and Guayaquil, Ecuador, one single-unit radiation therapy facility in Puebla, Mexico, and a 60% interest in three single-unit radiation therapy facilities in Rhode Island acquired in May 2024 [S1].
• Revenue drivers include number of sites, procedure volume, and reimbursement levels [S1].
• The company reported a net loss attributable to American Shared Hospital Services of $1,553,000 for the fiscal year ended December 31, 2025, compared to net income of $2,186,000 in 2024. The loss was primarily due to operational challenges in the direct patient segment, including physician turnover and equipment downtime [S1].
• Basic and diluted loss per share for 2025 was $0.23 [S1].
• The company’s liquidity position as of December 31, 2025 included cash and cash equivalents of $3,462,000, current assets of $17,720,000, and current liabilities of $23,444,000, resulting in a current ratio of 0.76 and a cash ratio of 0.15 [S1].
• The company’s credit agreement with Fifth Third Bank matures in April 2026, with ongoing discussions about potential extension; failure to extend could impact liquidity and going concern status [S1].
• Customer concentration is significant, with two customers accounting for approximately 26% and 31% of revenue in 2025, and four locations accounting for 81% of accounts receivable at year-end 2025 [S1].
• The company’s equipment is primarily sourced from Elekta, including Gamma Knife units and LINAC systems [S1].
• Recent news highlights include a 17% year-over-year revenue growth for Q1 2025 and expansion plans, as well as a strong revenue growth report in 2026 [N1][N3].
• The company held an earnings conference call for Q1 2025 on May 15, 2025 [N2].